Skip to main content

Table 2 Participant characteristics by subgroup

From: Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best–worst scaling experiment in caregivers and adult patients

Variable

Adults with Duchenne

Caregivers

Total

n

%

n

%

n

%

Mobility

 Uses wheelchair most or all the time

27

100.0

91

36.8

118

43.1

 Walks with assistance or better

156

63.2

156

56.9

Sex

 Male

27

100.0

53

21.5

80

29.2

 Female

194

78.5

194

70.8

Race/ethnicity

 White, non-Hispanic

17

63.0

193

78.1

210

76.6

 Black, non-Hispanic

0

0.0

4

1.6

4

1.5

 Hispanic, all-races

5

18.5

20

8.1

25

9.1

 Other, non-Hispanic

3

11.1

27

10.9

30

11.0

 Refused

2

7.4

3

1.2

5

1.8

Marital status

 Married or committed relationship

1

3.7

211

85.4

212

77.4

 Single

24

88.9

8

3.2

32

11.7

 Divorced or separated

0

0.0

27

10.9

27

9.9

 Widowed

0

0.0

1

0.4

1

0.4

 Refused

2

7.4

0

0.0

2

0.7

Educational attainment

 High school or less

14

51.9

49

19.8

63

23.0

 Technical school or associate degree

3

11.1

34

13.8

37

13.5

 Bachelor’s degree

3

11.1

94

38.1

97

35.4

 Graduate or professional degree

5

18.5

69

27.9

74

27.0

 Refused

2

7.4

1

0.4

3

1.1

Annual household income

 Less than $50,000

8

29.6

12

4.9

20

7.3

 $24,000 – $50,000

1

3.7

22

8.9

23

8.4

 $51,000 – $75,000

1

3.7

30

12.2

31

11.3

 $75,001 – $100,000

1

3.7

45

18.2

46

16.8

 More than $100,000

3

11.1

110

44.5

113

41.2

 Prefer not to answer or refused

13

48.2

28

11.3

41

15.0

Previous clinical trial participation

 Yes

5

18.5

128

51.8

133

48.5

 No

22

81.5

119

48.2

141

51.5

  1. N = 274. Percentages may not add up to 100% due to rounding